Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Sleep Apnoea (English, HTML)

View metadata and access the original English HTML file: Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Sleep Apnoea.

Format

HTML

Access

file-only

Publisher-reported update

2024-05-08

Health Canada carried out a safety review to look into the risk of sleep apnoea with the use of atypical antipsychotics. Sleep apnoea is a disorder that causes breaks in breathing or shallow breaths during sleep. This review was triggered by the submission of new safety information from the manufacturer of quetiapine (Seroquel) that included cases of sleep apnoea in patients using quetiapine.

Access original file